메뉴 건너뛰기




Volumn 17, Issue 4, 2015, Pages 555-565

Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients

Author keywords

IDH1 2 gene; KEAP1 NRF2 system; Malignant glioma; Prognosis

Indexed keywords

CARMUSTINE; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; KELCH LIKE ECH ASSOCIATED PROTEIN 1; NIMUSTINE; PROCARBAZINE; PROTEIN P62; TEMOZOLOMIDE; TRANSCRIPTION FACTOR NRF2; VINCRISTINE; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, HUMAN; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN; SIGNAL PEPTIDE;

EID: 84938700155     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou282     Document Type: Article
Times cited : (49)

References (34)
  • 1
    • 73349134695 scopus 로고    scopus 로고
    • NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
    • Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol. 2009;27(35):5874-5880.
    • (2009) J Clin Oncol. , vol.27 , Issue.35 , pp. 5874-5880
    • Wick, W.1    Hartmann, C.2    Engel, C.3
  • 2
    • 65349121788 scopus 로고    scopus 로고
    • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
    • Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
    • (2009) Lancet Oncol. , vol.10 , Issue.5 , pp. 459-466
    • Stupp, R.1    Hegi, M.E.2    Mason, W.P.3
  • 3
    • 7244253081 scopus 로고    scopus 로고
    • Nrf2-Keap1 defines a physiologically important stress response mechanism
    • Motohashi H, Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med. 2004;10(11):549-557.
    • (2004) Trends Mol Med. , vol.10 , Issue.11 , pp. 549-557
    • Motohashi, H.1    Yamamoto, M.2
  • 4
    • 78751703950 scopus 로고    scopus 로고
    • Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
    • Taguchi K, Motohashi H, Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells. 2011;16(2):123-140.
    • (2011) Genes Cells. , vol.16 , Issue.2 , pp. 123-140
    • Taguchi, K.1    Motohashi, H.2    Yamamoto, M.3
  • 5
    • 33750885385 scopus 로고    scopus 로고
    • Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer
    • Singh A, Misra V, Thimmulappa RK, et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006;3(10):e420.
    • (2006) PLoS Med. , vol.3 , Issue.10 , pp. e420
    • Singh, A.1    Misra, V.2    Thimmulappa, R.K.3
  • 6
    • 51649130168 scopus 로고    scopus 로고
    • Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
    • Shibata T, Ohta T, Tong KI, et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A. 2008;105(36):13568-13573.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , Issue.36 , pp. 13568-13573
    • Shibata, T.1    Ohta, T.2    Tong, K.I.3
  • 7
    • 53049105119 scopus 로고    scopus 로고
    • Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
    • Shibata T, Kokubu A, Gotoh M, et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology. 2008;135(4):1358-1368.
    • (2008) Gastroenterology , vol.135 , Issue.4 , pp. 1358-1368
    • Shibata, T.1    Kokubu, A.2    Gotoh, M.3
  • 8
    • 76649089973 scopus 로고    scopus 로고
    • Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth
    • Zhang P, Singh A, Yegnasubramanian S, et al. Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther. 2010;9(2):336-346.
    • (2010) Mol Cancer Ther. , vol.9 , Issue.2 , pp. 336-346
    • Zhang, P.1    Singh, A.2    Yegnasubramanian, S.3
  • 9
    • 79960958309 scopus 로고    scopus 로고
    • Keap1 mutations and NRF2 pathway activation in epithelial ovarian cancer
    • Konstantinopoulos PA, Spentzos D, Fountzilas E, et al. Keap1 mutations and NRF2 pathway activation in epithelial ovarian cancer. Cancer Res. 2011;71(15):5081-5089.
    • (2011) Cancer Res. , vol.71 , Issue.15 , pp. 5081-5089
    • Konstantinopoulos, P.A.1    Spentzos, D.2    Fountzilas, E.3
  • 10
    • 77954695549 scopus 로고    scopus 로고
    • Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features
    • Solis LM, Behrens C, Dong W, et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res. 2010;16(14):3743-3753.
    • (2010) Clin Cancer Res. , vol.16 , Issue.14 , pp. 3743-3753
    • Solis, L.M.1    Behrens, C.2    Dong, W.3
  • 11
    • 84862811895 scopus 로고    scopus 로고
    • Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma
    • Inoue D, Suzuki T, Mitsuishi Y, et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012;103(4):760-766.
    • (2012) Cancer Sci. , vol.103 , Issue.4 , pp. 760-766
    • Inoue, D.1    Suzuki, T.2    Mitsuishi, Y.3
  • 12
    • 80053439769 scopus 로고    scopus 로고
    • NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer
    • Shibata T, Kokubu A, Saito S, et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia. 2011;13(9):864-873.
    • (2011) Neoplasia. , vol.13 , Issue.9 , pp. 864-873
    • Shibata, T.1    Kokubu, A.2    Saito, S.3
  • 13
    • 77958113395 scopus 로고    scopus 로고
    • Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival
    • Wang J, Zhang M, Zhang L, et al. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J Surg Res. 2010;164(1):99-105.
    • (2010) J Surg Res. , vol.164 , Issue.1 , pp. 99-105
    • Wang, J.1    Zhang, M.2    Zhang, L.3
  • 14
    • 84899865579 scopus 로고    scopus 로고
    • NRF2 immunolocalization in human breast cancer patients as a prognostic factor
    • Onodera Y, Motohashi H, Takagi K, et al. NRF2 immunolocalization in human breast cancer patients as a prognostic factor. Endocr Relat Cancer. 2014;21(2):241-252.
    • (2014) Endocr Relat Cancer , vol.21 , Issue.2 , pp. 241-252
    • Onodera, Y.1    Motohashi, H.2    Takagi, K.3
  • 15
    • 84879666141 scopus 로고    scopus 로고
    • ERK and PI3 K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells
    • Cong ZX, Wang HD, Wang JW, et al. ERK and PI3 K signaling cascades induce Nrf2 activation and regulate cell viability partly through Nrf2 in human glioblastoma cells. Oncol Rep. 2013;30(2):715-722.
    • (2013) Oncol Rep. , vol.30 , Issue.2 , pp. 715-722
    • Cong, Z.X.1    Wang, H.D.2    Wang, J.W.3
  • 16
    • 84878187382 scopus 로고    scopus 로고
    • Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model
    • Ji XJ, Chen SH, Zhu L, et al. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model. Oncol Rep. 2013;30(1):157-164.
    • (2013) Oncol Rep. , vol.30 , Issue.1 , pp. 157-164
    • Ji, X.J.1    Chen, S.H.2    Zhu, L.3
  • 17
    • 56749156414 scopus 로고    scopus 로고
    • Analysis of the IDH1 codon 132 mutation in brain tumors
    • Balss J, Meyer J, Mueller W, et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008;116(6):597-602.
    • (2008) Acta Neuropathol , vol.116 , Issue.6 , pp. 597-602
    • Balss, J.1    Meyer, J.2    Mueller, W.3
  • 18
    • 52949127312 scopus 로고    scopus 로고
    • An integrated genomic analysis of human glioblastoma multiforme
    • Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807-1812.
    • (2008) Science , vol.321 , Issue.5897 , pp. 1807-1812
    • Parsons, D.W.1    Jones, S.2    Zhang, X.3
  • 19
    • 70349594347 scopus 로고    scopus 로고
    • Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
    • Sonoda Y, Kumabe T, Nakamura T, et al. Analysis of IDH1 and IDH2 mutations in Japanese glioma patients. Cancer Sci. 2009;100(10):1996-1998.
    • (2009) Cancer Sci. , vol.100 , Issue.10 , pp. 1996-1998
    • Sonoda, Y.1    Kumabe, T.2    Nakamura, T.3
  • 20
    • 84886439157 scopus 로고    scopus 로고
    • Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death
    • Mohrenz IV, Antonietti P, Pusch S, et al. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death. Apoptosis. 2013;18(11):1416-1425.
    • (2013) Apoptosis , vol.18 , Issue.11 , pp. 1416-1425
    • Mohrenz, I.V.1    Antonietti, P.2    Pusch, S.3
  • 21
    • 79952769109 scopus 로고    scopus 로고
    • Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation
    • Shibata T, Kokubu A, Miyamoto M, et al. Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol. 2011;178(3):1395-1402.
    • (2011) Am J Pathol. , vol.178 , Issue.3 , pp. 1395-1402
    • Shibata, T.1    Kokubu, A.2    Miyamoto, M.3
  • 22
    • 38349189124 scopus 로고    scopus 로고
    • Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS
    • Ohashi Y, Hirayama A, Ishikawa T, et al. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol Biosyst. 2008;4(2):135-147.
    • (2008) Mol Biosyst. , vol.4 , Issue.2 , pp. 135-147
    • Ohashi, Y.1    Hirayama, A.2    Ishikawa, T.3
  • 23
    • 84858796263 scopus 로고    scopus 로고
    • IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
    • Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature. 2012;483(7390):479-483.
    • (2012) Nature , vol.483 , Issue.7390 , pp. 479-483
    • Turcan, S.1    Rohle, D.2    Goenka, A.3
  • 24
    • 70249097408 scopus 로고    scopus 로고
    • Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
    • Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 2009;27(25):4150-4154.
    • (2009) J Clin Oncol. , vol.27 , Issue.25 , pp. 4150-4154
    • Sanson, M.1    Marie, Y.2    Paris, S.3
  • 25
    • 0026755187 scopus 로고
    • Regulation of human NAD (P) H: Quinone oxidoreductase gene. Role of AP-1 binding site contained within human antioxidant response element
    • Li Y, Jaiswal AK. Regulation of human NAD (P) H: quinone oxidoreductase gene. Role of AP-1 binding site contained within human antioxidant response element. J Biol Chem. 1992;267(21):15097-15104.
    • (1992) J Biol Chem. , vol.267 , Issue.21 , pp. 15097-15104
    • Li, Y.1    Jaiswal, A.K.2
  • 26
    • 0030956247 scopus 로고    scopus 로고
    • Constitutive and betanaphthoflavoneinduced expression of the human gammaglutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence
    • Mulcahy RT, Wartman MA, Bailey HH, et al. Constitutive and betanaphthoflavoneinduced expression of the human gammaglutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem. 1997;272(11):7445-7454.
    • (1997) J Biol Chem. , vol.272 , Issue.11 , pp. 7445-7454
    • Mulcahy, R.T.1    Wartman, M.A.2    Bailey, H.H.3
  • 27
    • 0036570346 scopus 로고    scopus 로고
    • Glutamate-cysteine ligase modifier subunit: Mouse Gclm gene structure and regulation by agents that cause oxidative stress
    • Solis WA, Dalton TP, Dieter MZ, et al. Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochem Pharmacol. 2002;63(9):1739-1754.
    • (2002) Biochem Pharmacol. , vol.63 , Issue.9 , pp. 1739-1754
    • Solis, W.A.1    Dalton, T.P.2    Dieter, M.Z.3
  • 28
    • 72049125350 scopus 로고    scopus 로고
    • Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
    • Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462(7274):739-744.
    • (2009) Nature , vol.462 , Issue.7274 , pp. 739-744
    • Dang, L.1    White, D.W.2    Gross, S.3
  • 29
    • 84862786878 scopus 로고    scopus 로고
    • Somatic mutations of the KEAP1 gene in common solid cancers
    • Yoo NJ, Kim HR, Kim YR, et al. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology. 2012;60(6):943-952.
    • (2012) Histopathology , vol.60 , Issue.6 , pp. 943-952
    • Yoo, N.J.1    Kim, H.R.2    Kim, Y.R.3
  • 30
    • 77950823830 scopus 로고    scopus 로고
    • Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer
    • Takahashi T, Sonobe M, Menju T, et al. Mutations in Keap1 are a potential prognostic factor in resected non-small cell lung cancer. J Surg Oncol. 2010;101(6):500-506.
    • (2010) J Surg Oncol. , vol.101 , Issue.6 , pp. 500-506
    • Takahashi, T.1    Sonobe, M.2    Menju, T.3
  • 31
    • 65349150503 scopus 로고    scopus 로고
    • IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
    • Watanabe T, Nobusawa S, Kleihues P, et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol. 2009;174(4):1149-1153.
    • (2009) Am J Pathol. , vol.174 , Issue.4 , pp. 1149-1153
    • Watanabe, T.1    Nobusawa, S.2    Kleihues, P.3
  • 32
    • 80052765905 scopus 로고    scopus 로고
    • Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations
    • Kim YH, Lachuer J, Mittelbronn M, et al. Alterations in the RB1 pathway in low-grade diffuse gliomas lacking common genetic alterations. Brain Pathol. 2011;21(6):645-651.
    • (2011) Brain Pathol. , vol.21 , Issue.6 , pp. 645-651
    • Kim, Y.H.1    Lachuer, J.2    Mittelbronn, M.3
  • 33
    • 80053215336 scopus 로고    scopus 로고
    • TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations
    • Kim YH, Pierscianek D, Mittelbronn M, et al. TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J Clin Pathol. 2011;64(10):850-852.
    • (2011) J Clin Pathol. , vol.64 , Issue.10 , pp. 850-852
    • Kim, Y.H.1    Pierscianek, D.2    Mittelbronn, M.3
  • 34
    • 84863764614 scopus 로고    scopus 로고
    • Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming
    • Mitsuishi Y, Taguchi K, Kawatani Y, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22(1):66-79.
    • (2012) Cancer Cell. , vol.22 , Issue.1 , pp. 66-79
    • Mitsuishi, Y.1    Taguchi, K.2    Kawatani, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.